Capromorelin increases food consumption,body weight,growth hormone,and sustained insulin‐like growth factor 1 concentrations when administered to healthy adult Beagle dogs |
| |
| Authors: | B Zollers L Rhodes R G Smith |
| |
| Institution: | 1. Aratana Therapeutics, Inc., Leawood, KS, USA;2. , Durham, NH, USA;3. Scripps Research Institute, Jupiter, FL, USA |
| |
| Abstract: | This study's objective was to determine the effects in dogs of oral capromorelin, a ghrelin agonist, at different doses for 7 days on food consumption, body weight and serum concentrations of growth hormone (GH), insulin‐like growth factor 1 (IGF‐1), and cortisol. Adult Beagles (n = 6) were dosed with placebo BID, capromorelin at 3.0 mg/kg SID, 4.5 mg/kg SID, or 3.0 mg/kg BID. Food consumption, body weight, serum capromorelin, GH, IGF‐1, and cortisol were measured at intervals on days 1, 4, 7, and 9. Capromorelin increased food consumption and body weight compared to placebo and caused increased serum GH, which returned to the baseline by 8 h postdose. The magnitude of the GH increase was less on days 4 and 7 compared to Day 1. IGF‐1 concentrations increased on Day 1 in capromorelin‐treated dogs and this increase was sustained through Day 7. Serum cortisol increased postdosing and returned to the baseline concentrations by 8 h. The magnitude of the increase was less on days 4 and 7 compared to Day 1. A dose of 3 mg/kg was chosen for further study in dogs based on this dose causing increased food consumption and sustained IGF‐1 serum concentrations that may increase lean muscle mass when administered over extended periods. |
| |
| Keywords: | |
|
|
